We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Heart MRI Scans Can Enable More Accurate COVID-19 Diagnoses and Target Treatments More Effectively

By HospiMedica International staff writers
Posted on 26 Feb 2021
Print article
Illustration
Illustration
A new study has shown that some patients who have been discharged from hospital following severe COVID-19 illness have evidence of damage to their heart on MRI scans which can help identify different patterns of injury to enable more accurate diagnoses, assess prognosis, and potentially target treatments more effectively.

In the study, researchers at Imperial College Healthcare (London, UK) studied 148 patients who had been hospitalized with severe COVID-19 and who showed raised levels of a protein called troponin in blood tests. Troponin is released into the blood when the heart is injured and can indicate possible damage. The patients studied had been very unwell, with one in three also having been on a ventilator in intensive care. They found that around half of these patients had evidence of damage to the heart on MRI scans performed, on average, around 10 weeks after discharge. Damage included inflammation of the heart muscle, scarring or death of heart tissue, restricted blood supply to the heart and combinations of all three.

Some patients who are hospitalized with COVID-19 have raised troponin levels during the most critical phase of their illness, which is when the body mounts an exaggerated immune response to the infection. Raised levels can occur when an artery becomes blocked or there is inflammation of the heart, but it can be challenging for clinicians to identify the extent or cause of the damage without imaging. The results also show that, despite being very unwell and having raised troponin levels, around half of the patients studied had no evidence on their scan of damage to their heart.

COVID-19 patients who had abnormal troponin levels had MRI scans of the heart after discharge as part of their normal care and these were compared with those from a control group of patients who had not had COVID-19, as well as with 40 healthy volunteers. The study found that around half of patients had evidence of injury, but also that different patterns occurred, suggesting that the heart may be at risk of different types of injury. The researchers also noted that in some cases MRI scans may be showing evidence of existing damage due to the patients’ underlying conditions. The researchers hope that the findings will provide insight into new ways of preventing injury to the heart in the first place, such as early treatment for blood clots, but also for identifying patients who would benefit from treatments to protect their heart function in the future.

“Raised troponin levels are associated with worse outcomes in COVID-19 patients and it is important to understand more about the extent and potential causes of heart damage,” said Dr. Graham Cole, consultant cardiologist at Imperial College Healthcare, who led the study. “MRI scans help identify different patterns of injury, which may enable us to make more accurate diagnoses, assess prognosis, and potentially target treatments more effectively.”

Related Links:
Imperial College Healthcare

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Bronchoscopy Head Support
Reison 10-330

Print article

Channels

Critical Care

view channel
Image: The stretchable microneedle electrode arrays (Photo courtesy of Zhao Research Group)

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

The field of personalized medicine is transforming rapidly, with advancements like wearable devices and home testing kits making it increasingly easy to monitor a wide range of health metrics, from heart... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more